Media coverage about MetLife (NYSE:MET) has trended somewhat positive this week, Accern reports. Accern rates the sentiment of media coverage by reviewing more than 20 million blog and news sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. MetLife earned a media sentiment score of 0.10 on Accern’s scale. Accern also assigned press coverage about the financial services provider an impact score of 47.1267103591003 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the company’s share price in the immediate future.

These are some of the news stories that may have impacted Accern’s scoring:

MetLife (NYSE MET) traded down 0.94% on Wednesday, reaching $48.31. The company’s stock had a trading volume of 6,215,260 shares. The firm’s 50 day moving average is $54.67 and its 200-day moving average is $53.10. MetLife has a 12 month low of $39.50 and a 12 month high of $58.09. The firm has a market cap of $52.53 billion, a P/E ratio of 542.81 and a beta of 1.46.

MetLife (NYSE:MET) last posted its earnings results on Wednesday, August 2nd. The financial services provider reported $1.30 earnings per share for the quarter, topping analysts’ consensus estimates of $1.28 by $0.02. The firm had revenue of $17.39 billion for the quarter, compared to analysts’ expectations of $17.11 billion. MetLife had a net margin of 0.30% and a return on equity of 8.51%. The company’s revenue was up 2.5% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.83 earnings per share. On average, equities research analysts anticipate that MetLife will post $4.93 EPS for the current year.

The business also recently announced a quarterly dividend, which will be paid on Wednesday, September 13th. Shareholders of record on Monday, August 7th will be paid a dividend of $0.40 per share. The ex-dividend date is Thursday, August 3rd. This represents a $1.60 dividend on an annualized basis and a dividend yield of 3.31%. MetLife’s payout ratio is presently 1,777.98%.

Several research analysts have recently commented on MET shares. TheStreet raised MetLife from a “c” rating to a “b-” rating in a report on Monday, July 24th. Wells Fargo & Company reissued a “buy” rating on shares of MetLife in a report on Saturday, July 1st. Zacks Investment Research raised MetLife from a “hold” rating to a “buy” rating and set a $59.00 target price on the stock in a report on Tuesday, April 11th. Royal Bank Of Canada reissued a “buy” rating and issued a $62.00 target price on shares of MetLife in a report on Wednesday, July 12th. Finally, Keefe, Bruyette & Woods reissued a “buy” rating and issued a $59.00 target price on shares of MetLife in a report on Thursday, August 3rd. Two equities research analysts have rated the stock with a sell rating, six have issued a hold rating, seven have given a buy rating and one has issued a strong buy rating to the company. The stock currently has a consensus rating of “Hold” and an average target price of $59.10.

TRADEMARK VIOLATION NOTICE: This piece was originally reported by Daily Political and is the sole property of of Daily Political. If you are accessing this piece on another website, it was copied illegally and reposted in violation of US and international copyright and trademark legislation. The legal version of this piece can be accessed at https://www.dailypolitical.com/2017/08/09/metlife-met-given-daily-media-sentiment-score-of-0-10.html.

About MetLife

MetLife, Inc is a provider of life insurance, annuities, employee benefits and asset management. The Company’s segments include U.S.; Asia; Latin America; Europe, the Middle East and Africa (EMEA); MetLife Holdings; Brighthouse Financial, and Corporate & Other. Its U.S. segment is organized into Group Benefits, Retirement and Income Solutions and Property & Casualty businesses.

Insider Buying and Selling by Quarter for MetLife (NYSE:MET)

Receive News & Ratings for MetLife Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife Inc. and related companies with MarketBeat.com's FREE daily email newsletter.